ROYAL BANK OF CANADA - ALDER BIOPHARMACEUTICALS INC ownership

ALDER BIOPHARMACEUTICALS INC's ticker is ALDR and the CUSIP is 014339105. A total of 133 filers reported holding ALDER BIOPHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of ALDER BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2019$656,000
-12.4%
34,774
-45.4%
0.00%
Q2 2019$749,000
-17.5%
63,695
-4.2%
0.00%
Q1 2019$908,000
+37.0%
66,505
+2.7%
0.00%
Q4 2018$663,000
-13.0%
64,732
+41.4%
0.00%
Q3 2018$762,000
+27.4%
45,782
+20.7%
0.00%
Q2 2018$598,000
-17.1%
37,935
-33.2%
0.00%
Q1 2018$721,000
+86.8%
56,810
+68.6%
0.00%
Q4 2017$386,000
+247.7%
33,689
+271.2%
0.00%
Q3 2017$111,000
+296.4%
9,075
+274.1%
0.00%
Q2 2017$28,000
-99.3%
2,426
-98.7%
0.00%
-100.0%
Q1 2017$3,958,000
-8.0%
190,253
-8.0%
0.00%0.0%
Q4 2016$4,304,000
-33.1%
206,897
+5.4%
0.00%
-50.0%
Q3 2016$6,434,000
+51.3%
196,334
+15.3%
0.00%
+33.3%
Q2 2016$4,253,000
+141666.7%
170,354
+159109.3%
0.00%
Q4 2015$3,000
-93.8%
107
-92.7%
0.00%
Q3 2015$48,000
-76.0%
1,463
-61.3%
0.00%
Q2 2015$200,000
-14.5%
3,779
-53.5%
0.00%
Q1 2015$234,000
-46.6%
8,132
-45.9%
0.00%
Q4 2014$438,000
+69.8%
15,045
-26.0%
0.00%
Q3 2014$258,000
-30.6%
20,322
+9.7%
0.00%
Q2 2014$372,00018,5280.00%
Other shareholders
ALDER BIOPHARMACEUTICALS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Novo Holdings A/S 6,402,366$128,496,0006.43%
Cormorant Asset Management, LP 150,000$3,011,0000.80%
PFM Health Sciences, LP 738,027$14,812,0000.30%
Partner Investment Management, L.P. 27,893$560,0000.11%
Spark Investment Management LLC 32,100$642,0000.10%
PointState Capital LP 275,000$5,519,0000.07%
DRIEHAUS CAPITAL MANAGEMENT LLC 97,809$1,963,0000.06%
CADIAN CAPITAL MANAGEMENT, LP 100,000$2,007,0000.06%
Nicholas Investment Partners, LP 50,456$1,013,0000.06%
Baker Brothers Advisors 153,350$3,078,0000.04%
View complete list of ALDER BIOPHARMACEUTICALS INC shareholders